241 related articles for article (PubMed ID: 25962824)
1. An Improved Nonradioactive Screening Method Identifies Genistein and Xanthohumol as Potent Inhibitors of Iodothyronine Deiodinases.
Renko K; Schäche S; Hoefig CS; Welsink T; Schwiebert C; Braun D; Becker NP; Köhrle J; Schomburg L
Thyroid; 2015 Aug; 25(8):962-8. PubMed ID: 25962824
[TBL] [Abstract][Full Text] [Related]
2. Identification of iopanoic acid as substrate of type 1 deiodinase by a novel nonradioactive iodide-release assay.
Renko K; Hoefig CS; Hiller F; Schomburg L; Köhrle J
Endocrinology; 2012 May; 153(5):2506-13. PubMed ID: 22434082
[TBL] [Abstract][Full Text] [Related]
3. Screening the ToxCast Phase 1 Chemical Library for Inhibition of Deiodinase Type 1 Activity.
Hornung MW; Korte JJ; Olker JH; Denny JS; Knutsen C; Hartig PC; Cardon MC; Degitz SJ
Toxicol Sci; 2018 Apr; 162(2):570-581. PubMed ID: 29228274
[TBL] [Abstract][Full Text] [Related]
4. Strong induction of iodothyronine deiodinases by chemotherapeutic selenocompounds.
Stoedter M; Renko K; Ibáñez E; Plano D; Becker NP; Martitz J; Palop JA; Calvo A; Sanmartín C; Schomburg L
Metallomics; 2015 Feb; 7(2):347-54. PubMed ID: 25579002
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific thyroid hormone regulation of gene transcripts encoding iodothyronine deiodinases and thyroid hormone receptors in striped parrotfish (Scarus iseri).
Johnson KM; Lema SC
Gen Comp Endocrinol; 2011 Jul; 172(3):505-17. PubMed ID: 21549118
[TBL] [Abstract][Full Text] [Related]
6. Three members of the iodothyronine deiodinase family, dio1, dio2 and dio3, are expressed in spatially and temporally specific patterns during metamorphosis of the flounder, Paralichthys olivaceus.
Itoh K; Watanabe K; Wu X; Suzuki T
Zoolog Sci; 2010 Jul; 27(7):574-80. PubMed ID: 20608846
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of iodothyronine deiodinases (DIO1, DIO3) genes are not associated with recurrent depressive disorder.
Gałecka E; Talarowska M; Maes M; Su KP; Górski P; Szemraj J
Pharmacol Rep; 2016 Oct; 68(5):913-7. PubMed ID: 27351946
[TBL] [Abstract][Full Text] [Related]
8. Deiodinases and the Three Types of Thyroid Hormone Deiodination Reactions.
Sabatino L; Vassalle C; Del Seppia C; Iervasi G
Endocrinol Metab (Seoul); 2021 Oct; 36(5):952-964. PubMed ID: 34674502
[TBL] [Abstract][Full Text] [Related]
9. The thyroid hormone degrading type 3 deiodinase is the primary deiodinase active in murine epidermis.
Huang MP; Rodgers KA; O'Mara R; Mehta M; Abuzahra HS; Tannenbaum AD; Persons K; Holick MF; Safer JD
Thyroid; 2011 Nov; 21(11):1263-8. PubMed ID: 21936673
[TBL] [Abstract][Full Text] [Related]
10. Thyroid hormone deiodinases--a selenoenzyme family acting as gate keepers to thyroid hormone action.
Köhrle J
Acta Med Austriaca; 1996; 23(1-2):17-30. PubMed ID: 8767511
[TBL] [Abstract][Full Text] [Related]
11. Modification of cardiac thyroid hormone deiodinases expression in an ischemia/reperfusion rat model after T3 infusion.
Sabatino L; Kusmic C; Iervasi G
Mol Cell Biochem; 2020 Dec; 475(1-2):205-214. PubMed ID: 32780210
[TBL] [Abstract][Full Text] [Related]
12. Thyronamines are isozyme-specific substrates of deiodinases.
Piehl S; Heberer T; Balizs G; Scanlan TS; Smits R; Koksch B; Köhrle J
Endocrinology; 2008 Jun; 149(6):3037-45. PubMed ID: 18339710
[TBL] [Abstract][Full Text] [Related]
13. Deiodinases control local cellular and systemic thyroid hormone availability.
Köhrle J; Frädrich C
Free Radic Biol Med; 2022 Nov; 193(Pt 1):59-79. PubMed ID: 36206932
[TBL] [Abstract][Full Text] [Related]
14. A Nonradioactive DEHAL Assay for Testing Substrates, Inhibitors, and Monitoring Endogenous Activity.
Renko K; Hoefig CS; Dupuy C; Harder L; Schwiebert C; Köhrle J; Schomburg L
Endocrinology; 2016 Dec; 157(12):4516-4525. PubMed ID: 27732086
[TBL] [Abstract][Full Text] [Related]
15. The thyroid hormone converting enzyme human deiodinase 1 is inhibited by gold ions from inorganic salts, organic substances, and by small-size nanoparticles.
Weber AG; Birk B; Müller C; Schneider S; van Ravenzwaay B; Funk-Weyer D; Landsiedel R
Chem Biol Interact; 2022 Jan; 351():109709. PubMed ID: 34662569
[TBL] [Abstract][Full Text] [Related]
16. Insights into the Mechanism of Human Deiodinase 1.
Rodriguez-Ruiz A; Braun D; Pflug S; Brol A; Sylvester M; Steegborn C; Schweizer U
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628173
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone transporters in health and disease: advances in thyroid hormone deiodination.
Köhrle J
Best Pract Res Clin Endocrinol Metab; 2007 Jun; 21(2):173-91. PubMed ID: 17574002
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the Mechanistic Linkages Between Iodothyronine Deiodinase Inhibition and Impaired Thyroid-Mediated Growth and Development in Xenopus laevis Using Iopanoic Acid.
Haselman JT; Olker JH; Kosian PA; Korte JJ; Denny JS; Tietge JE; Hornung MW; Degitz SJ
Toxicol Sci; 2022 Apr; 187(1):139-149. PubMed ID: 35179606
[TBL] [Abstract][Full Text] [Related]
19. Development of a validated liquid chromatography/tandem mass spectrometry method for the distinction of thyronine and thyronamine constitutional isomers and for the identification of new deiodinase substrates.
Piehl S; Heberer T; Balizs G; Scanlan TS; Köhrle J
Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3286-96. PubMed ID: 18821722
[TBL] [Abstract][Full Text] [Related]
20. Repositioning of Cefuroxime as novel selective inhibitor of the thyroid hormone activating enzyme type 2 deiodinase.
Sagliocchi S; Murolo M; Cicatiello AG; Miro C; Nappi A; Di Cicco E; Torabinejad S; La Civita E; Romano V; Terracciano D; Stornaiuolo M; Dentice M
Pharmacol Res; 2023 Mar; 189():106685. PubMed ID: 36773711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
